Glucoamylase variants and polynucleotides encoding same

US2020131491A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2020131491-A1
Application numberUS-201816603639-A
CountryUS
Kind codeA1
Filing dateApr 10, 2018
Priority dateApr 11, 2017
Publication dateApr 30, 2020
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to glucoamylase variants having an increase in raw starch activity compared to the guy-coamylase disclosed as SEQ ID NO: 2, comprising one or more modifications in the catalytic domain and/or one or more modifications in the starch binding domain selected from: a) at least one, preferably at least two, preferably at least three, preferably at least four of: V18M, T43K, N112L, T116R, A117Q, G120S, A271F, Y295W, Q318Y; and/or b) Introducing at least three, preferably at least four substitutions selected from the group: S458C, S458SCGG, S458SGGC, A493V, A518K, E520Q, N527M, S540K, R, S(G)546P, T(V)549W, N503R, N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.

First claim

Opening claim text (preview).

1 . A glucoamylase variant, having increased raw starch hydrolytic activity at pH=4.0, T=32° C., compared to the glucoamylase disclosed in SEQ ID NO: 2, wherein the variant is derived from a glucoamylase having a catalytic domain comprising amino acids 1-454 of SEQ ID NO: 2 or 1-454 of SEQ ID NO: 4, a linker comprising amino acids 455-462 of SEQ ID NO: 2 or amino acids 455-465 of SEQ ID NO: 4 and a starch binding domain comprising amino acids 463-556 of SEQ ID NO: 2 or amino acids 466-559 of SEQ ID NO: 4, and wherein the variant further comprises a substitution at one or more positions selected from the group consisting of: V18M+T43K+S95P+A121P+Q318Y+A518K+N527M+T549W; V18M+T43K+S95P+T116R+A121P+Q318Y+N539R+I541Y+T543V+A545S+S546PCGV+G547S+S548T+T549A; S95P+A121P+Y295W+T116R+N539R+I541Y+T543V+A545S+S546PCGV+G547S+S548T+T549A; T43K+S95P+A121P+Y295W+Q318Y+N539R+I541Y+T543V+A545S+S546PCGV+G547S+S548T+T549A; T43K+S95P+G120S+A121P+Y295W+Q318Y+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; V18M+T43K+S95P+T116R+A121P+Q318Y+S458SCGG+N527M+T(V)549W; V18M+T43K+S95P+A121P+Q318Y+S458SCGG+N527M+T(V)549W+N503R; V18M+T43K+S95P+A121P+Q318Y+N539R+I541Y+T543V+A545S+S546PCGV+G547S+S548T+T549A; T43K+Q318Y+S95P+A121P+Y295W+S458SCGG+N527M+T(V)549W; S95P+A121P+Y295W+G120S+N539R+I541Y+T543V+A545S+S546PCGV+G547S+S548T+T549A; V18M+T43K+S95P+A121P+Q318Y+S458SCGG+N527M T(V)549W; S95P+A121P+Y295W+N539R+I541Y+T543V+A545S+S546PCGV+G547S+S548T+T549A; T43K+S95P+A121P+Y295W+Q318Y+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; S95P+T116R+A121P+Y295W+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; T43K+S95P+A121P+Y295W+Q318Y+N527M+T(V)549W+N503R; S95P+A121P+Y295W+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; V18M+T43K+S95P+A121P+A518K+N527M+T549W; T43K+S95P+G120S+A121P+Y295W+Q318Y+A518K+N527M+T(V)549W; T43K+S95P+A121P+Q318Y+A493V+A518K+N527M+T549W; S95P+G120S+A121P+Y295W+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; V18M+T43K+S95P+A121P+Y295W+A518K+N527M+T549W; T43K+S95P+A121P+Y295W+Q318Y+N527M+T(V)549W; T43K+S95P+A121P+Q318Y+N527M+T549W; V18M+T43K+S95P+A121P+Q318Y+N527M+T549W; S95P+A121P+Y295W+T116R+N527M+T(V)549W; V18M+T43K+S95P+T116R+A121P+Q318Y+A493V+N527M+T549W; V18M+T43K+S95P+A121P+Q318Y+A493V+N527M+T549W; T43K+S95P+A121P+Y295W+Q318Y+A518K+N527M+T(V)549W; S95P+A121P+Y295W+A117Q+N527M+T(V)549W; V18M+T43K+S95P+A121P+Q318Y+A493V+A518K+N527M+T549W; T43K+S95P+A121P+Q318Y+A518K+N527M+T549W; V18M+T43K+S95P+T116R+A121P+Q318Y+N527M+T549W; T43K+S95P+A121P+Q318Y+A493V+N527M+T549W; S95P+T116R+A121P+Y295W+A518K+N527M+T(V)549W; V18M+T43K+S95P+A121P+Q318Y+A518K+T(V)549W; T43K+S95P+A121P+Y295W+Q318Y+A518K+N527M+T549W; V18M+T43K+S95P+T116R+A121P+Q318Y+A518K+T549W; S95P+A121P+Y295W+Q318Y+N527M+T(V)549W; S95P+G120S+A121P+Y295W+N527M+T(V)549W; S95P+A121P+Y295W+A518K+N527M+T(V)549W; S95P+A121P+Y295W+N527M+T(V)549W; S95P+N112L+A121P+Y295W+N527M+T(V)549W; S95P+A121P+Y295W+N527M+T(V)549W; V18M+T43K+S95P+A121P+Q318Y+A518K+N527M+T549W; T43K+S95P+A121P+Y295W+Q318Y+N527M+T549W; S95P+G120S+A121P+Y295W+A518K+N527M+T(V)549W; S95P+N112L+A121P+Y295W+A518K+N527M+T(V)549W; V18M+T43K+S95P+A121P+Q318Y+A518K+T549W; S95P+A121P+Y295W+A493V+A518K+E520Q+T549W; S95P+A121P+Y295W+A518K+N527M+T549W; S95P+A121P+Y295W+A518K+T(V)549W; S95P+A121P+Y295W+A518K+N527M; S95P+A121P+Y295W+S458C+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; S95P+A121P+Y295W+N527M+T549W; S95P+A121P+A271F+Y295W+A518K+N527M+T549W; S95P+A121P+Y295W+A493V; S95P+A121P+Y295W+S540K; S95P+A121P+Y295W+S540R; S95P+A121P+Y295W+A518K+N527M; S95P+A121P+Y295W+S458SGGC+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; T43K+S95P+A121P+Y295W+N527M+T(V)549W; and S95P+A121P+Y295W+S458SCGG+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; wherein the position numbering corresponds to amino acid positions in the amino acid sequence set forth in SEQ ID NO: 2; and wherein the variants have at least 85%, but less than 100%, sequence identity to the amino acid sequence of SEQ ID NO: 2. 2 . The glucoamylase variant of claim 1 , wherein the variant is derived from a glucoamylase having a catalytic domain comprising amino acids 1-454 of SEQ ID NO: 2, a linker comprising amino acids 455-465 of SEQ ID NO: 4 and a starch binding domain comprising amino acids 466-559 of SEQ ID NO: 4, and wherein the variant comprises a combination of specific substitutions selected from the group consisting of: V18M+T43K+S95P+T116R+A121P+Q318Y+N539R+I541Y+T543V+A545S+S546PCGV+G547S+S548T+T549A; S95P+A121P+Y295W+T116R+N539R+I541Y+T543V+A545S+S546PCGV+G547S+S548T+T549A; T43K+S95P+A121P+Y295W+Q318Y+N539R+I541Y+T543V+A545S+S546PCGV+G547S+S548T+T549A; T43K+S95P+G120S+A121P+Y295W+Q318Y+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; V18M+T43K+S95P+T116R+A121P+Q318Y+S458SCGG+N527M+T(V)549W; V18M+T43K+S95P+A121P+Q318Y+S458SCGG+N527M+T(V)549W+N503R; V18M+T43K+S95P+A121P+Q318Y+N539R+I541Y+T543V+A545S+S546PCGV+G547S+S548T+T549A; T43K+S95P+A121P+Y295W+Q318Y+S458SCGG+N527M+T(V)549W; S95P+A121P+Y295W+G120S+N539R+I541Y+T543V+A545S+S546PCGV+G547S+S548T+T549A; V18M+T43K+S95P+A121P+Q318Y+S458SCGG+N527M T(V)549W; S95P+A121P+Y295W+N539R+I541Y+T543V+A545S+S546PCGV+G547S+S548T+T549A; T43K+S95P+A121P+Y295W+Q318Y+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; S95P+T116R+A121P+Y295W+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; T43K+S95P+A121P+Y295W+Q318Y+N527M+T(V)549W+N503R; and S95P+A121P+Y295W+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; and wherein the increase in raw starch hydrolytic activity compared to SEQ ID NO: 2 is at least 30%. 3 . The glucoamylase variant of claim 1 , wherein the variant is derived from the glucoamylase of SEQ ID NO: 2, and wherein the variant comprises a combination of specific substitutions selected from the group consisting of: V18M+T43K+S95P+A121P+Q318Y+A518K+N527M+T549W; V18M+T43K+S95P+A121P+A518K+N527M+T549W; T43K+S95P+A121P+Q318Y+A493V+A518K+N527M+T549W; V18M+T43K+S95P+A121P+Y295W+A518K+N527M+T549W; T43K+S95P+A121P+Q318Y+N527M+T549W; V18M+T43K+S95P+A121P+Q318Y+N527M+T549W; V18M+T43K+S95P+T116R+A121P+Q318Y+A493V+N527M+T549W; V18M+T43K+S95P+A121P+Q318Y+A493V+N527M+T549W; V18M+T43K+S95P+A121P+Q318Y+A493V+A518K+N527M+T549W; T43K+S95P+A121P+Q318Y+A518K+N527M+T549W; V18M+T43K+S95P+T116R+A121P+Q318Y+N527M+T549W; T43K+S95P+A121P+Q318Y+A493V+N527M+T549W; T43K+S95P+A121P+Y295W+Q318Y+A518K+N527M+T549W; V18M+T43K+S95P+T116R+A121P+Q318Y+A518K+T549W; V18M+T43K+S95P+A121P+Q318Y+A518K+N527M+T549W; T43K+S95P+A121P+Y295W+Q318Y+N527M+T549W; V18M+T43K+S95P+A121P+Q318Y+A518K+T549W; S95P+A121P+Y295W+A493V+A518K+E520Q+T549W; S95P+A121P+Y295W+A518K+N527M+T549W; S95P+A121P+Y295W+N527M+T549W; S95P+A121P+A271F+Y295W+A518K+N527M+T549W; S95P+A121P+Y295W+A493V; S95P+A121P+Y295W+S540K; S95P+A121P+Y295W+S540R; and S95P+A121P+Y295W+A518K+N527M; and wherein the increase in raw starch hydrolytic activity compared to SEQ ID NO: 2 is at least 5%. 4 . The glucoamylase variant of claim 1 , wherein the variant is derived from a glucoamylase having a catalytic domain comprising amino acids 1-454 of SEQ ID NO: 2, a linker comprising amino acids 455-465 of SEQ ID NO: 4 and a starch binding domain comprising amino acids 466-559 of SEQ ID NO: 4, and wherein the variant comprises a substitution at one or more positions selected from the group consisting of: T43K+S95P+G120S+A121P+Y295W+Q318Y+A518K+N527M+T(V)549W; S95P+G120S+A121P+Y295W+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; T43K+S95P+A121P+Y295W+Q318Y+N527M+T(V)549W; S95P+A121P+Y295W+T116R+N527M+T(V)549W; T43K+S95P+A121P+Y295W+Q318Y+A518K+N527M+T(V)549W; S95P+A121P+Y295W+A117Q+N527M+T(V)549W; S95P+T116R+A121P+Y295W+A518K+N527M+T(V)549W; V18M+T43K+S95P+A121P+Q318Y+A518K+T(V)549W; S95P+A121P+Y295W+Q318Y+N527M+T(V)549W; S

Assignees

Inventors

Classifications

  • produced by the action of a carbohydrase {(EC 3.2.x)}, e.g. by alpha-amylase {, e.g. by cellulase, hemicellulase} · CPC title

  • C12N9/2428Primary

    Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase · CPC title

  • Monosaccharides (2-ketogulonic acid C12P7/60) · CPC title

  • Biofuels, e.g. bio-diesel · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2020131491A1 cover?
The present invention relates to glucoamylase variants having an increase in raw starch activity compared to the guy-coamylase disclosed as SEQ ID NO: 2, comprising one or more modifications in the catalytic domain and/or one or more modifications in the starch binding domain selected from: a) at least one, preferably at least two, preferably at least three, preferably at least four of: V18M, T…
Who is the assignee on this patent?
Novozymes As
What technology area does this patent fall under?
Primary CPC classification C12N9/2428. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Apr 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).